

Relexxii is an extended-release methylphenidate tablet for ADHD. Learn about its uses, dosing, how it works, costs, and what makes it different.
Relexxii (methylphenidate hydrochloride extended-release) is a once-daily, oral ADHD medication approved for adults up to age 65 and children ages 6 and older. It belongs to the CNS stimulant drug class and is classified as a Schedule II controlled substance. Relexxii is manufactured by Vertical Pharmaceuticals, a subsidiary of Osmotica Pharmaceuticals.
If you've heard of Concerta, Relexxii uses the same osmotic-controlled release oral delivery system (OROS) technology — meaning the medication is released gradually through a laser-drilled hole in the tablet over the course of 6-7 hours, providing steady symptom control throughout the day.
Relexxii is FDA-approved for one primary indication:
ADHD is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with daily functioning. Relexxii helps manage these symptoms by increasing the availability of two key neurotransmitters — dopamine and norepinephrine — in the brain.
While methylphenidate as a class is sometimes used off-label for narcolepsy and treatment-resistant depression (as augmentation therapy), Relexxii is specifically approved and marketed for ADHD.
Relexxii contains methylphenidate, which works by blocking the reuptake of dopamine and norepinephrine into presynaptic neurons. In simple terms, it prevents your brain from reabsorbing these neurotransmitters too quickly, keeping more of them available in the spaces between neurons where they do their work — helping you focus, control impulses, and regulate attention.
What makes Relexxii unique is its osmotic delivery system. The tablet has three layers:
This design means you take one pill in the morning and get consistent medication delivery throughout the day — no peaks and valleys like you might get with immediate-release methylphenidate. For a deeper dive, read: How Does Relexxii Work? Mechanism of Action Explained in Plain English.
Relexxii comes in seven tablet strengths:
The typical dose range is 18 mg to 72 mg once daily. Your doctor will usually start at a lower dose and increase gradually based on your response and tolerability.
A note about the tablet shell: Because Relexxii uses a non-digestible osmotic shell, you may see what looks like the whole tablet in your stool. This is normal — the medication has already been absorbed, and you're just passing the empty shell.
Relexxii is not appropriate for everyone. You should not take it if you have:
Like all stimulant medications, Relexxii has potential side effects. The most common include:
Serious but rare side effects include cardiovascular events (increased blood pressure, heart rate, and in rare cases sudden death or stroke in patients with heart conditions), psychiatric symptoms (psychosis, mania, aggression), priapism, and peripheral vasculopathy (Raynaud's phenomenon).
Relexxii also carries a boxed warning about the high potential for abuse and dependence, as is standard for all Schedule II stimulants.
For a complete breakdown of side effects and when to seek emergency care, read: Relexxii Side Effects: What to Expect and When to Call Your Doctor.
Cost varies significantly depending on whether you're getting brand-name Relexxii or its generic equivalent:
Most insurance plans cover generic methylphenidate ER on Tier 2 or Tier 3. Brand-name Relexxii may require prior authorization or step therapy (trying the generic first).
The manufacturer offers a Relexxii Savings Card for commercially insured patients — eligible patients may pay as little as $0 per month. Visit relexxii.com/savings for details.
For patients without insurance, GoodRx offers exclusive discounted pricing on the generic, and organizations like NeedyMeds and RxAssist can help connect patients with additional financial assistance.
For more cost-saving strategies, read: How to Save Money on Relexxii.
Relexxii isn't the only methylphenidate ER option on the market. Here's how it compares to some common alternatives:
The methylphenidate ER shortage that began in late 2022 has affected multiple manufacturers and formulations. As of early 2026, the shortage has improved — the DEA increased production quotas by up to 25% in October 2025 — but intermittent supply disruptions continue at the pharmacy level.
Brand-name Relexxii has generally had more stable supply than some generic alternatives. If your pharmacy is out of stock, use Medfinder to quickly check which pharmacies near you have Relexxii available. For a detailed breakdown, read: How to Check If a Pharmacy Has Relexxii in Stock (Without Calling).
Thanks to a partnership between Relexxii's manufacturer and Medfinder, you can use Medfinder's medication locating services completely free of charge.
Relexxii can be prescribed by psychiatrists, primary care physicians, pediatricians, neurologists, and qualified nurse practitioners or physician assistants. If you're looking for a provider, start with your current PCP — many are comfortable prescribing ADHD medications without a specialist referral.
For a complete guide to finding a prescriber, read: How to Find a Doctor Who Can Prescribe Relexxii Near You.
Relexxii is a well-established, once-daily ADHD treatment that uses proven osmotic delivery technology to provide consistent symptom control throughout the day. It's available in a wide range of strengths, has an affordable generic option, and — despite the ongoing stimulant shortage — has maintained relatively stable supply.
The manufacturer of Relexxii has partnered with Medfinder to provide medication locating services free of charge. Visit medfinder.com to find Relexxii in stock near you at no cost.
Whether you're newly diagnosed or considering switching from another ADHD medication, talk to your doctor about whether Relexxii is the right fit. And if cost or availability is a concern, tools like Medfinder and the Relexxii Savings Card can help.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.